<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>2007-7459</journal-id>
<journal-title><![CDATA[Horizonte sanitario]]></journal-title>
<abbrev-journal-title><![CDATA[Horiz. sanitario]]></abbrev-journal-title>
<issn>2007-7459</issn>
<publisher>
<publisher-name><![CDATA[Universidad Juárez Autónoma de Tabasco, División Académica de Ciencias de la Salud]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S2007-74592022000300373</article-id>
<article-id pub-id-type="doi">10.19136/hs.a21n3.4941</article-id>
<title-group>
<article-title xml:lang="es"><![CDATA[Manifestaciones bucales en pacientes con SIDA bajo terapia antirretroviral en un hospital en Perú]]></article-title>
<article-title xml:lang="en"><![CDATA[Oral manifestations in AIDS patients receiving antiretroviral therapy in a referral hospital in Peru]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Ramos-Tejada]]></surname>
<given-names><![CDATA[Katherine-Liset]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Romero-Gamboa]]></surname>
<given-names><![CDATA[Julio-César]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[La-Serna-Solari]]></surname>
<given-names><![CDATA[Paola-Beatriz]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,Universidad Señor de Sipán  ]]></institution>
<addr-line><![CDATA[ Pimentel]]></addr-line>
<country>Peru</country>
</aff>
<aff id="Af2">
<institution><![CDATA[,Señor de Sipán  ]]></institution>
<addr-line><![CDATA[ Pimentel]]></addr-line>
<country>Peru</country>
</aff>
<aff id="Af3">
<institution><![CDATA[,Universidad Señor de Sipán  ]]></institution>
<addr-line><![CDATA[ Pimentel]]></addr-line>
<country>Peru</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>12</month>
<year>2022</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>12</month>
<year>2022</year>
</pub-date>
<volume>21</volume>
<numero>3</numero>
<fpage>373</fpage>
<lpage>377</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_arttext&amp;pid=S2007-74592022000300373&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_abstract&amp;pid=S2007-74592022000300373&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_pdf&amp;pid=S2007-74592022000300373&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="es"><p><![CDATA[Resumen  Objetivo: Determinar la prevalencia de las manifestaciones bucales, en pacientes con SIDA bajo terapia antirretroviral en un Hospital Referencial en Perú.  Materiales y métodos: Estudio prospectivo, no experimental, transversal y cuantitativo. Se contó con una población de 380 y una muestra de 191 pacientes, que cumplieron los criterios de selección. El instrumento utilizado fue una ficha de recolección de datos adaptada, que consta de dos partes, en una los datos personales y en otra las manifestaciones bucales más frecuentes.  Resultados: La prevalencia de las manifestaciones bucales en pacientes con SIDA bajo terapia antirretroviral en un 59.50%, siendo la candidiasis oral la más frecuente con un 35.5%; El predominio de estas manifestaciones bucales es mayor en el género masculino con un 67% y en el rango de edades entre 18-25 años en un 57%.  Conclusiones: Existe alta prevalencia de manifestaciones bucales en pacientes con SIDA bajo terapia antirretroviral, siendo la más frecuente la candidiasis oral, en el género masculino y en menores de 25 años.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[Abstract  Objective: TodeterminetheprevalenceoforalmanifestationsinAIDS patients, under antiretroviral therapy in a referral hospital in Perú.  Materials and methods: A prospective, not experimental, cross - sectional and quantitative study. There was a population consisting of 380 and a sample of 191 patients who met the selection criteria. The instrument was an adapted data collection form that consist of two parts, in one the personal data and in another the most frequent oral manifestations.  Results: The prevalence of oral manifestations in AIDS patients under antiretroviral therapy in 59.50% with oral candidiasis being the most frequent with 35.5%, the prevalence of oral manifestations is higher in male gender with a 67% and in the age range between 18-25 years old in a 57%.  Conclusions: There is a high prevalence of oral manifestations in patients with AIDS under antiretroviral therapy, the most frequent being oral candidiasis in males and in those under 25 years old.]]></p></abstract>
<kwd-group>
<kwd lng="es"><![CDATA[VIH-1]]></kwd>
<kwd lng="es"><![CDATA[Antirretrovirales]]></kwd>
<kwd lng="es"><![CDATA[Carga viral]]></kwd>
<kwd lng="es"><![CDATA[Linfocitos T]]></kwd>
<kwd lng="en"><![CDATA[HIV-1]]></kwd>
<kwd lng="en"><![CDATA[Antiretroviral]]></kwd>
<kwd lng="en"><![CDATA[Viral load]]></kwd>
<kwd lng="en"><![CDATA[T lymphocytes]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<label>1</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Bodhade]]></surname>
<given-names><![CDATA[AS]]></given-names>
</name>
<name>
<surname><![CDATA[Ganvir]]></surname>
<given-names><![CDATA[SM]]></given-names>
</name>
<name>
<surname><![CDATA[Hazarey]]></surname>
<given-names><![CDATA[VK]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Manifestaciones orales de infección por VIH y su correlación con el recuento de CD4]]></article-title>
<source><![CDATA[J Oral Sci]]></source>
<year>2011</year>
<volume>53</volume>
<page-range>203-11</page-range></nlm-citation>
</ref>
<ref id="B2">
<label>2</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Patil]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Chaurasia]]></surname>
<given-names><![CDATA[VR]]></given-names>
</name>
<name>
<surname><![CDATA[Babaji]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Ramesh]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Jhamb]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Sharma]]></surname>
<given-names><![CDATA[AM]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[El efecto de la terapia antirretroviral altamente activa sobre la prevalencia de la manifestación oral en pacientes infectados por el virus de la inmunodeficiencia humana en Karnataka, India]]></article-title>
<source><![CDATA[Eur J Dent]]></source>
<year>2015</year>
<volume>9</volume>
<page-range>47-52</page-range></nlm-citation>
</ref>
<ref id="B3">
<label>3</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Okoye]]></surname>
<given-names><![CDATA[AA]]></given-names>
</name>
<name>
<surname><![CDATA[Picker]]></surname>
<given-names><![CDATA[LJ]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Depleción de células T CD4 (+) en la infección por VIH: mecanismos de falla inmunológica]]></article-title>
<source><![CDATA[Immunol Rev]]></source>
<year>2013</year>
<volume>254</volume>
<page-range>54-64</page-range></nlm-citation>
</ref>
<ref id="B4">
<label>4</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Rocío]]></surname>
<given-names><![CDATA[Peña-Alonso-Y]]></given-names>
</name>
<name>
<surname><![CDATA[Luis]]></surname>
<given-names><![CDATA[Romano-Mazzotti]]></given-names>
</name>
<name>
<surname><![CDATA[Aarón]]></surname>
<given-names><![CDATA[Pacheco-Ríos]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Adolescente con síndrome de inmunodeficiencia adquirida de transmisión perinatal]]></article-title>
<source><![CDATA[Bol. Med. Hosp. Infant. Mex]]></source>
<year>2009</year>
<volume>66</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>373-81</page-range></nlm-citation>
</ref>
<ref id="B5">
<label>5</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Patton]]></surname>
<given-names><![CDATA[LL]]></given-names>
</name>
<name>
<surname><![CDATA[McKaig]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Strauss]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Rogers]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Eron]]></surname>
<given-names><![CDATA[JJ]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Jr Cambio de la prevalencia de manifestaciones orales del virus de la inmunodeficiencia humana en la era del tratamiento con inhibidores de la proteasa]]></article-title>
<source><![CDATA[Oral Surg Oral Med Oral Pathol Oral Radiol Endod]]></source>
<year>2000</year>
<volume>89</volume>
<page-range>299-304</page-range></nlm-citation>
</ref>
<ref id="B6">
<label>6</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ceballos-Salobreña]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Gaitán-Cepeda]]></surname>
<given-names><![CDATA[LA]]></given-names>
</name>
<name>
<surname><![CDATA[Ceballos-García]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Lezama-Del-Valle]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Lesiones orales en pacientes con VIH / SIDA sometidos a tratamiento antirretroviral de gran actividad, incluidos los inhibidores de la proteasa: ¿una nueva cara del SIDA oral?]]></article-title>
<source><![CDATA[AIDS Patient Care STDS]]></source>
<year>2000</year>
<volume>14</volume>
<page-range>627-35</page-range></nlm-citation>
</ref>
<ref id="B7">
<label>7</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Navarrete]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
</person-group>
<source><![CDATA[Frecuencia de lesiones orales en pacientes adultos VIH/SIDA del Hospital San Juan de Dios]]></source>
<year>2014</year>
<publisher-loc><![CDATA[Santiago,Chile ]]></publisher-loc>
<publisher-name><![CDATA[UniversidaddeChile]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B8">
<label>8</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Vera]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
<name>
<surname><![CDATA[Manoj]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Alexander]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Rao]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Venugopal]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Hosthor]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[A relationship between CD4 count and oral manifestations of human immunodeficiency virus-infected patients on highly active antiretroviral therapy in urban population]]></article-title>
<source><![CDATA[J Oral Maxillofac Pathol]]></source>
<year>2016</year>
<volume>20</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>419-26</page-range></nlm-citation>
</ref>
<ref id="B9">
<label>9</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Lourenço]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Figueiredo]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Oral lesions in HIV infected individuals from Ribeirão Preto, Brazil]]></article-title>
<source><![CDATA[Med Oral Patol Oral Cir Bucal]]></source>
<year>2008</year>
<volume>13</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>281-6</page-range></nlm-citation>
</ref>
<ref id="B10">
<label>10</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Jonathan]]></surname>
<given-names><![CDATA[Harris-Ricardo]]></given-names>
</name>
<name>
<surname><![CDATA[Martha]]></surname>
<given-names><![CDATA[Rebolledo-Cobos]]></given-names>
</name>
<name>
<surname><![CDATA[Antonio-José]]></surname>
<given-names><![CDATA[Díaz-Caballero]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Lesiones orales en pacientes VIH/SIDA asociadas a tratamiento antirretroviral y carga viral]]></article-title>
<source><![CDATA[Salud, Barranquilla]]></source>
<year>2012</year>
<volume>28</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>373-81</page-range></nlm-citation>
</ref>
<ref id="B11">
<label>11</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Figueira-de-Araújo]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Figueiredo-de-Oliveira]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Cruz]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Vieira]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Ferreira]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Most common oral manifestations in pediatric patients HIV positive and the effect of highly active antiretroviral therapy. Principais manifestações bucais em pacientes pediátricos HIV positivos e o efeito da terapia antirretroviral altamente ativa]]></article-title>
<source><![CDATA[Cien Saude Colet]]></source>
<year>2018</year>
<volume>23</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>115-22</page-range></nlm-citation>
</ref>
<ref id="B12">
<label>12</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Quispe]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
</person-group>
<source><![CDATA[Manifestaciones orales en pacientes con VIH/ SIDA atendidos en los hospitales del MINSA en la ciudad de Cusco]]></source>
<year>2013</year>
<publisher-loc><![CDATA[Cusco, Perú ]]></publisher-loc>
<publisher-name><![CDATA[Universidad Nacional de San Antonio Abad del Cusco]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B13">
<label>13</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Patil]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Chaurasia]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
<name>
<surname><![CDATA[Babaji]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Ramesh]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Jhamb]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Sharma]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The effect of highly active antiretroviral therapy on the prevalence of oral manifestation in human immunodeficiency virus-infected patients in Karnataka, India]]></article-title>
<source><![CDATA[Eur J Dent]]></source>
<year>2015</year>
<volume>9</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>47-52</page-range></nlm-citation>
</ref>
</ref-list>
</back>
</article>
